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Abstract
Microsimulation models (MSMs) are used to inform policy by predicting population-level
outcomes under different scenarios. MSMs simulate individual-level event histories that mark
the disease process (such as the development of cancer) and the effect of policy actions (such
as screening) on these events. MSMs often have many unknown parameters; calibration is the
process of searching the parameter space to select parameters that result in accurate MSM
prediction of a wide range of targets. We develop Incremental Mixture Approximate Bayesian
Computation (IMABC) for MSM calibration, which results in a simulated sample from the
posterior distribution of model parameters given calibration targets. IMABC begins with a
rejection-based ABC step, drawing a sample of points from the prior distribution of model pa-
rameters and accepting points that result in simulated targets that are near observed targets.
Next, the sample is iteratively updated by drawing additional points from a mixture of multi-
variate normal distributions and accepting points that result in accurate predictions. Posterior
estimates are obtained by weighting the final set of accepted points to account for the adaptive
sampling scheme. We demonstrate IMABC by calibrating CRC-SPIN 2.0, an updated version
of a MSM for colorectal cancer (CRC) that has been used to inform national CRC screening
guidelines.
1 Introduction
Microsimulation models (MSMs) are used to inform policy by predicting population-level outcomes
under different policy scenarios. MSMs are characterized by simulation of agents that represent
individual members of an idealized population of interest. For each agent, the model simulates
event histories that catalog landmarks in the disease process. In general, disease processes modeled
are not directly observable, though outcomes from these processes may be observed. For example,
the process of developing colorectal cancer (CRC) cannot be observed, but the prevalence of both
precursor lesions (adenomas) and preclinical (asymptomatic) CRC can be estimated from screening
trials, and CRC incidence can be observed from national registry data.
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Model calibration involves selecting parameter values that result in model predictions that
are consistent with observed data and expected findings. Once parameters are selected, MSMs
can be used to make predictions about population trends in disease outcomes, effectiveness of
interventions, and the comparative effectiveness of interventions, especially those without direct
empirical comparisons. For example, models have been used to inform U.S. Preventive Services
Task Force screening guidelines for breast (Mandelblatt et al., 2016), cervical (Kim et al., 2017),
colorectal (Knudsen et al., 2016), and lung cancer (de Koning et al., 2014) by comparing the
effectiveness of different screening regimens.
MSM calibration involves searching a high dimensional parameter space to predict many targets.
Several approaches have been proposed. The simplest calibration method involves perturbing
parameters one at a time and evaluating the goodness of fit to calibration data, but this is only
feasible when calibrating a few parameters. Directed searches, such as the Nelder-Mead algorithm
(Nelder and Mead, 1965), provide a derivative free hill-climb to identify a single best value for each
parameter. Kong et al. (2009) used search algorithms from engineering (simulated annealing and a
genetic algorithm) for model calibration. Bayesian calibration methods estimate the joint posterior
distribution of MSM parameters, which provides information about parameter uncertainty and
enables estimation of functions of parameters. Rutter et al. (2009) used Markov Chain Monte Carlo
(MCMC) to simulate draws from the posterior distribution of MSM parameters given calibration
targets. However, MCMC can be difficult and costly to apply to MSM calibration and because
MCMC is based on a process of sequentially updating draws, it is not easy to parallelize the process
to take advantage of modern computing resources.
Approximate Bayesian Computation (ABC) offers an alternative approach to MSM calibration.
ABC is a likelihood-free technique for simulating draws from the posterior distribution that ap-
proximates likelihood-based algorithms by choosing parameters that produce a close match to data
rather than calculating the likelihood (Marin et al., 2012; Conlan et al., 2012). The validity of ABC
algorithms, in the sense that they result in samples from the approximate posterior distribution,
relies on the validity of the corresponding exact algorithms (Sisson et al., 2007). The idea under-
lying ABC is simple. For a parameter θ with prior distribution pi(θ) and observed data y, we can
write the posterior probability as p(θ|y) = p(y|θ)pi(θ) implying that we can approximate p(θ|y) by
sampling θ from pi(·) and retaining only points with p(y|θ) ≈ 1. However, ABC is inefficient and
can fail when the parameter space is high dimensional, when there are many calibration targets,
or when the prior distributions are very different from the posterior distributions. McKinley et al.
(2018) found that popular ABC variants that improve the algorithm’s efficiency were not compu-
tationally feasible for calibrating stochastic epidemiological models. We propose an Incremental
Mixture ABC (IMABC) approach for MSM model calibration that begins with a basic rejection-
sampling ABC step (e.g., Pritchard et al., 1999) and then incrementally adds points to regions
where targets are well predicted.
In the next sections we describe the CRC-SPIN MSM for the natural history of colorectal cancer
(CRC) (§2), calibration targets used to inform CRC-SPIN model parameters (§3), the IMABC
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calibration approach (§4), and results of CRC-SPIN model calibration based on IMABC (§5). We
conclude with general remarks about the proposed approach and discussion of future work (§6).
2 Microsimulation Model for the Natural History of Colorectal
Cancer
The ColoRectal Cancer Simulated Population Incidence and Natural history model (CRC-SPIN)
(Rutter et al., 2009; Rutter and Savarino, 2010) describes the natural history of CRC based on
the adenoma-carcinoma sequence (Muto et al., 1975; Leslie et al., 2002). Four model components
describe the natural history of CRC: 1) adenoma risk; 2) adenoma growth; 3) transition from
adenoma to preclinical cancer; and 4) transition from preclinical to clinical cancer (sojourn time).
CRC-SPIN has been used to provide guidance to the Centers for Medicare and Medicaid Ser-
vices (CMS) (Zauber et al., 2009) and to inform U.S. Preventive Services Task Force CRC screening
guidelines (Knudsen et al., 2016). Model validation, based on comparison of model predictions to
observed outcomes, revealed that while CRC-SPIN predicted many aspects of CRC well (includ-
ing clinically detected cancer, cancer mortality, and the effectiveness of screening), it predicted
detection of too few preclinical cancers at screening, indicating that the simulated times spent in
the preclinical cancer phase (sojourn times) were too short (Rutter et al., 2016). In this paper
we present CRC-SPIN 2.0, an update to the original CRC-SPIN 1.0. CRC-SPIN 2.0 contains 21
calibrated parameters (Table 1). Because this is a model recalibration, prior distributions are based
on results from the previous calibration of CRC-SPIN 1.0 (Rutter et al., 2009). In this section, we
provide an overview of the model. Additional details are provided in Appendix §A and online at
cisnet.cancer.gov (National Cancer Institute, 2018).
2.1 Adenoma Risk Model
The occurrence of adenomas is modeled using a non-homogeneous Poisson process with a piecewise
age-effect. We assume zero risk before age 20. We focus on CRC in adults because CRC is very rare
before age 20, with incidence of about one in 10 million (Koh et al., 2015). The ith agent’s baseline
instantaneous risk of an adenoma at age a = 20 years is given by ψi(20) = exp(α0i + α1femalei)
where α0i ∼ N(A, σα) and α1 captures the difference in risk for women (femalei = 1 indicates agent
i is female). Adenoma risk changes over time, generally increasing with age, a process we model
using a linear change-point for log-risk with knots at ages 50, 60, and 70.
log(ψi(a)) = α0i + α1sexi + δ(a ≥ 20) min(a− 20, 30)α20
+ δ(a ≥ 50) min((a− 50), 10)α50
+ δ(a ≥ 60) min((a− 60), 10)α60
+ δ(a ≥ 70)(a− 70)α70
(1)
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Table 1: Summary of CRC Microsimulation Model Components. Calibrated parameters associated
with the 4 components of the natural history model, including parameter notation, associated equa-
tions, prior distributions and posterior estimates (mean and 95% credible interval). TN[a,b](µ,σ)
denotes a truncated normal distribution with mean µ and standard deviation σ, restricted to the
interval (a, b). U(a,b) denotes a Uniform distribution over (a, b). Refer to section 2 for details of
the 4 model components.
Prior Posterior Estimates
Component Distribution Mean 95% CI
Adenoma Risk (eqn 1)
Baseline log-risk A ∼ TN[−6.7,−6.1](-6.4,0.25) -6.36 (-6.65,-6.03)
Standard deviation, baseline log-risk σα ∼ U(0.75,1.75) 1.28 (0.86,1.69)
Female α1 ∼ TN[−0.7,−0.3](-0.5,0.1) -0.61 (-0.69,-0.49)
Age effect, age ∈ [20, 50) α20 ∼ TN[0.02,0.05](0.04,0.06) 0.041 (0.033,0.049)
Age effect, age ∈ [50, 60) α50 ∼ TN[0.01,0.05](0.03,0.01) 0.028 (0.012,0.046)
Age effect, age ∈ [60, 70) α60 ∼ TN[−0.01,0.05](0.03,0.01) 0.013 (-0.007,0.039)
Age effect, age ≥ 70 α70 ∼ U(-0.02,0.03) 0.008 (-0.016,0.028)
Time to 10mm (eqn 2)
Shape, colon β1C ∼ U(1.1,5) 1.32 (1.12,1.57)
Shape, rectum β1R ∼ U(1.1,5) 3.30 (1.68,4.84)
Scale, colon∗ β2C ∼ U(10.7,40) 38.1 (35.6,39.9)
Scale, rectum∗ β2R ∼ U(10.7,40) 16.4 (13.5,19.3)
Intercept γ0 ∼ TN[2.6,3.6](3.1,0.25) 3.23 (3.07,3.42)
Female (versus male) γ1 ∼ TN[−0.3,0.3](-0.06,0.2) -0.17 (-0.26,-0.09)
Rectal (versus colon) γ2 ∼ U(-0.25,0.25) -0.07 (-0.24,0.15)
Female & rectal γ3 ∼ U(-0.25,0.25) 0.12 (-0.03,0.23)
Age at initiation γ4 ∼ TN[−0.024,0.002](-0.008,0.004) -0.009 (-0.014,-0.004)
Female & age at initiation γ5 ∼ U(-0.004,0.004) 0.001 (-0.003,0.004)
Rectal & age at initiation γ6 ∼ U(-0.004,0.004) 0.000 (-0.004,0.003)
Female, rectal, & age at initiation γ7 ∼ U(-0.004,0.004) 0.000 (-0.004,0.004)
Mean Sojourn Time (eqn 4)
Colon τC ∼ U(1.5,5.0) 1.91 (1.52,2.65)
Rectum τR ∼ U(1.5,5.0) 2.32 (1.55,3.55)
∗Scale parameters, β2, were also restricted to range from 10(− ln(0.25))1/β1 to (− ln(0.0001))1/β1 ,
corresponding to the probability of an adenoma reaching 10mm within 10 years ranging from
0.0001 to 0.25.
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2.2 Adenoma Growth Model
For each adenoma, we simulate a hypothetical time to reach 10mm, t10mm, which may exceed the
agent’s lifespan. We assume that t10mm has a Fre`chet distribution with shape parameter β1, scale
parameter β2, and cumulative distribution function given by
F (t) = exp
[
−
(
t
β2
)−β1]
(2)
for t ≥ 0, with E(t10mm) = β2Γ(1− 1/β1) and median(t10mm) = β2 ln(2)−1/β1 . Prior distributions
for adenoma growth parameters specify that most adenomas grow very slowly. We allow different
scale and shape parameters for adenomas in the colon and rectum.
Adenoma size at any point in time is simulated using a von Bertalanffy growth curve model
(Tjørve and Tjørve, 2010, see also §A). The simulated time to reach 10mm is used in combination
with the growth curve model to calculate the adenoma growth rate parameter.
2.3 Model for Transition from Adenoma to Preclinical Invasive Cancer
For the jth adenoma in the ith agent the size at transition to preclinical cancer (in mm) is simulated
using a lognormal distribution; the underlying (exponentiated) normal distribution is assumed to
have standard deviation 0.5 and mean
µij = γ0 + γ1femalei + γ2rectumij + γ3femaleirectumij+(
γ4 + γ5femalei + γ6rectumij + γ7femaleirectumij
)
ageij .
(3)
Where rectumij is an indicator of rectal versus colon location and ageij is the age at adenoma
initiation. Based on this model, the probability that an adenoma transitions to preclinical cancer
increase with increasing size. The expected size at transition is given by exp(µγ + 0.125), with
median exp(µγ) and variance 0.28 exp(2µγ +0.25). Most adenomas do not reach transition size and
small adenomas are unlikely to transition to cancer. For example, if µγ = 3.5 then the probability
of transition to preclinical cancer is less than 1×10−5 at 10mm, 0.008 at 15mm and 0.16 at 20mm.
2.4 Model for Sojourn Time
Sojourn time is the time from the transition to preclinical (asymptomatic) CRC and clinical (symp-
tomatic and detected) cancer. We simulate sojourn time using a Weibull distribution with shape
parameter fixed at 5:
f(x) =
(5
τ
)(x
τ
)4
exp
(
−
(x
τ
)5)
(4)
so that E(x) = τΓ(1.2) and V ar(x) = τ2
(
Γ(1.4) − Γ(1.2)2
)
. By fixing the shape parameter, we
focus on distributions with a limited range of skewness to disallow distributions with heavy right
tails while retaining enough flexibility to model plausible sojourn time distributions. We allow
5
different values of τ for cancers in the colon and rectum. Prior distributions for sojourn time
parameters allow the mean (and standard deviation) of sojourn time to range from 1.4 (sd 0.32) to
6.4 years (sd 1.5).
2.5 Simulation of Lifespan and Colorectal Cancer Survival
Once a cancer becomes clinically detectable, we simulate stage and size at clinical detection and
survival. Stage and tumor size at clinical detection are based on SEER data from 1975 to 1979,
prior to diffusion of CRC screening (National Cancer Institute, 2004). Simulated survival time after
CRC diagnosis is based on a Cox proportional hazards model, estimated using SEER data from
individuals diagnosed with CRC from 1975 through 2003 (Rutter et al., 2013). CRC survival is
based on the first diagnosed CRC and depends on sex, age at diagnosis, cancer location (colon or
rectum) and stage at diagnosis.
Other-cause mortality is modeled using survival probabilities based on product-limit estimates
for age and birth-year cohorts from the National Center for Health Statistics Databases (National
Center for Health Statistics, 2000).
3 Calibration Data
Calibration data are derived from published studies, and typically take the form of summary statis-
tics with known distributions, such as binomial, multinomial, and Poisson. We calibrate to 37
targets from six sources: SEER registry data (National Cancer Institute, 2004, 16 targets, §3.1)
and five published studies (21 targets, §3.2). We also bounded adenoma growth parameters, based
on information from a recent study of repeated screening colonoscopies (Ponugoti and Rex, 2017),
so that the probability of an adenoma reaching 10mm within 10 years ranged from 0.0001 to 0.25,
by requiring 10(− ln(0.25))1/β1 ≤ β2 ≤ 10(− ln(0.0001))1/β1 .
Calibration targets are based on individual-level data that is reported in aggregate. Calibration
requires simulating targets by simulating a set of agents with risk that is similar to the study
population based on age, gender, and prior screening patterns, and the time period of the study,
which may affect both overall and cancer-specific mortality.
3.1 SEER Registry Data
SEER colon and rectal cancer incidence rates in 1975-1979 are a key calibration target (Table 2).
Incidence rates reported are per 100,000 individuals. These rates are based on the first observed
invasive colon or rectal cancer during the years 1975-1979, the most recent period prior to dissem-
ination of CRC screening tests. We assume that given the SEER population size, the number of
incident CRC cases in any year follows a binomial distribution.
To simulate SEER incidence rates, we generate a population of individuals from 20 to 100, with
an age- and sex-distribution that matches the SEER 1978 population (to capture risk-levels within
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Table 2: Observed and Predicted Annual Incidence of Clinically Detected Cancers in 1975-1979,
per 100,000 individuals.
Observed Tolerance Posterior Predicted
Location Gender Age Mean Interval Mean 95% CI
Colon Female 20-49 4.8 (2.8, 6.8) 3.5 (2.8, 4.8)
50-59 43.3 (31.3, 55.2) 46.3 (37.0, 54.2)
60-69 100.7 (79.7, 121.7) 106.0 (89.8, 119.9)
70-84 216.7 (185.6, 247.8) 210.1 (187.7, 239.3)
Colon Male 20-49 4.5 (2.5, 6.5) 3.4 (2.6, 4.7)
50-59 45.9 (33.2, 58.6) 51.0 (41.4, 58.1)
60-69 121.4 (96.6, 146.2) 126.2 (107.0, 143.5)
70-84 268.4 (224.6, 312.2) 261.6 (228.7, 301.4)
Rectal Female 20-49 1.9 (0.6, 3.1) 1.7 (0.7, 2.8)
50-59 20.4 (12.2, 28.6) 20.4 (13.8, 27.3)
60-69 42.5 (28.9, 56.1) 41.9 (31.7, 53.1)
70-84 73.9 (55.7, 92.1) 73.2 (58.1, 89.7)
Rectal Male 20-49 2.3 (0.9, 3.7) 2.4 (1.3, 3.5)
50-59 30.0 (19.7, 40.3) 31.7 (23.1, 39.5)
60-69 71.4 (52.4, 90.4) 67.9 (54.5, 83.4)
70-84 128.0 (97.7, 158.3) 120.5 (100.0, 146.9)
each age category), who are free from clinically detected CRC. Model-predicted CRC incidence is
based on the number of people who develop CRC in the next year.
3.2 Other Published Targets
Table 3 summarizes calibration targets from five studies. To simulate these targets, we generated
separate populations for each target that match the age and gender distribution of study partici-
pants during the time-period of the study. One study (Church, 2004) describing the pathology of
lesions (i.e., adenomas and preclinical cancers) did not provide information about the age or sex of
patients, and so we simulated a population that was 50% male with an average age of 65 (standard
deviation of 5), and an age range of 20 to 90 years.
Simulation of targets in Table 3 also requires simulating the detection of lesions (adenomas
and preclinical cancers). Sensitivity is a function of lesions size, and is informed by back-to-back
colonoscopy studies (Hixson et al., 1990; Rex et al., 1997, additional details provided in §A). We
assume that study participants are free from symptomatic (clinically detectable) CRC and have not
been screened for CRC prior to the study. This is a reasonable assumption because studies used
for model calibration were conducted prior to widespread screening, or were based on minimally
screened samples. CRC screening guidelines have been in place since the late 1990s (Winawer
et al., 1997), and screening rates have since risen steadily (Meissner et al., 2006; Centers for Disease
Control & Prevention, 2011).
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Table 3: Observed and Predicted Calibration Targets from Published Studies
Tolerance Posterior Predicted
Target Mean Interval Mean 95% CI
Corley et al. (2013)
Adenoma Prevalence, Women 50-54 15 (12.9, 20.8) 16.8 (14.1, 19.9)
Adenoma Prevalence, Women 55-59 18 (15.5, 25.0) 20.3 (17.4, 23.6)
Adenoma Prevalence, Women 60-64 22 (19.4, 30.1) 23.8 (20.6, 27.1)
Adenoma Prevalence, Women 65-69 24 (20.6, 33.4) 27.0 (23.5, 30.4)
Adenoma Prevalence, Women 70-74 26 (21.5, 37.0) 29.9 (26.1, 33.4)
Adenoma Prevalence, Women ≥75 26 (20.8, 37.7) 33.2 (29.0, 37.2)
Adenoma Prevalence, Men 50-54 25 (22.1, 34.2) 26.0 (22.7,29.6)
Adenoma Prevalence, Men 55-59 29 (25.6, 39.7) 30.7 (26.8,34.6)
Adenoma Prevalence, Men 60-64 31 (27.5, 42.3) 35.1 (30.9,39.3)
Adenoma Prevalence, Men 65-69 34 (29.6, 46.9) 39.2 (34.4,43.8)
Adenoma Prevalence, Men 70-74 39 (33.2, 54.6) 42.7 (37.4,47.7)
Adenoma Prevalence, Men ≥75 38 (31.6, 53.9) 46.6 (40.4,52.1)
Pickhardt et al. (2003)∗
Percent of Detected Adenomas ≥ 10mm 9.2 (5.2, 13.2) 12.2 (10.7, 13.2)
Imperiale et al. (2000)
Detected Preclinical Cancers per 1,000 People 6.0 (0.3, 117.1) 2.4 (1.8, 5.3)
Lieberman et al. (2008)∗
Preclinical CRCs per 1,000 Lesions 6− 9mm 2.5 (0.0, 8.4) 4.7 (2.1, 7.6)
Preclinical CRCs per 1,000 Lesions ≥ 10mm 32.8 (11.6, 54.0) 41.4 (29.2, 52.9)
Church (2004)
Preclinical CRCs per 1,000 Lesions [6, 10)mm 2.4 (0.0, 10.3) 5.6 (2.5,9.0)
Preclinical CRCs per 1,000 Lesions ≥ 10mm 42.3 (12.6, 72.1) 36.7 (24.3, 49.0)
∗Size was reported categorically as ≤ 5mm, 6 to 9mm, and ≥ 10mm. We operationalized these
categories as: [1, 5.5) mm, [5.5, 9.5) mm and ≥ 9.5 mm
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4 Posterior Inference via Incremental Mixture Approximate Bayesian
Computation (IMABC)
The basic rejection-based ABC algorithm (Tavare et al., 1997; Pritchard et al., 1999) generates
model parameter vectors θ from the prior distribution, pi(θ), then uses the model to simulate data,
y∗. Draws that result in simulated data that are similar to observed data, y, are accepted. Similarity
between y∗ and y is based on user-defined summary statistics, a distance metric, and a tolerance
level that defines the distance of acceptable points.
In practice, simulating θ from the prior distribution can be very inefficient because the prior
and posterior distributions are often poorly aligned. Many versions of ABC have been developed
to address inefficiencies. Two popular variants are ABC-MCMC (Marjoram et al., 2003) and
sequential Monte Carlo ABC (ABC-SMC, Sisson et al., 2007; Toni et al., 2009). ABC-MCMC
involves proposing a new value of θ by sampling u from a user-specified jumping distribution, q(·),
that is centered at zero with θ(t+1) = θ(t)+u. If simulated data based on θ(t+1) are within tolerance
levels for observed data then, similarly to MCMC, θ(t+1) is accepted with a probability equal to the
minimum of 1 and q(θ
(t+1)|θ(t))pi(θ(t+1))
q(θ(t)|θ(t+1))pi(θ(t)) . Drawbacks of ABC-MCMC include the usual problems with
MCMC, such as correlated samples, low acceptance rates, the possibility of getting stuck in low
posterior probability regions, and slow mixing requiring simulation of very long chains. ABC-SMC
is based on importance sampling with the prior used as the proposal distribution. ABC-SMC starts
by simulating a set of draws from the prior distribution. Each subsequent set of draws is simulated
by drawing an (importance) weighted sample from the previous set of draws and for each sampled
point adding a random deviate u that is drawn from a user-specified jumping distribution. For
each sampled point this process is repeated until the perturbed point is accepted (i.e., falls within
the tolerance interval). When using the ABC-SMC approach, users specify the total number of
iterations, T , and a sequence of T increasingly stringent tolerance intervals, which require accepted
points to be nearer to targets as the algorithm proceeds. After T iterations, draws from the posterior
distribution are simulated by drawing a weighted sample of θ’s using final importance weights that
are based on the sequence of jumping distributions. The population Monte Carlo ABC algorithm
(ABC-PMC) is closely related to ABC-SMC, and also draws on importance sampling (Beaumont
et al., 2009; Marin et al., 2012). ABC-PMC uses a multivariate normal jumping distribution with
covariance matrix that is based on prior draws.
In general, ABC and its variants can be impractical or can fail when the parameter space is
high dimensional, or there are many summary statistics that the simulated data must approximate
(Blum and Francois, 2010). We propose a new ABC approach that we call incremental mixture ap-
proximate Bayesian computation (IMABC), which is well-suited to MSM calibration which involves
both high dimensional parameter spaces and many calibration targets. IMABC is an approximate
Bayesian version of adaptive importance sampling, similar to IMIS (Steele et al., 2006; Raftery and
Bao, 2010), with samples drawn from the parameter space using a proposal distribution that is a
mixture of normal distributions. Posterior estimates are based on accepted draws that are weighted
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to account for differences between the prior and proposal distrbutions. IMABC is most similar to
the ABC-PMC approach (Beaumont et al., 2009). IMABC adds new points in regions near a subset
of points that produce simulated targets closest to observed targets, whereas ABC-PMC samples
points based on an approximation to the joint distribution using importance weights.
4.1 The IMABC algorithm
The IMABC algorithm begins with a rejection-sampling ABC step, and updates this initial sample
by adding points near a set of “best” points that result in simulated targets that are closest to
corresponding observed targets.
Let O1, . . . , OJ denote the J calibration targets, which we assume are summary statistics.
We specify tolerance bounds around targets based on (1 − αj) × 100% confidence intervals, for
j = 1, ..., J . Let α = (α1, α2, . . . , αJ). The IMIS algorithm updates tolerance intervals so they
become more stringent in later iterations. Let α(0) be the alpha-levels used for tolerance intervals
for the initial ABC step, α(t) are alpha-levels for the tth iteration, and α∗ are the final (user-
specified) alpha-levels, corresponding to convergence of the IMABC algorithm. When searching
a high dimensional parameter space, it is practical to begin with very wide tolerance intervals,
corresponding to small values of α. Final alpha-levels used to calculate tolerance intervals may
vary across targets depending on the quality of and confidence in calibration targets.
Let Sij denote the jth simulated target (corresponding to Oj) for the ith sampled point, and
let δj(θi, αj) = 1 if Sij falls within the (1−αj)× 100% confidence interval for target Oj . We use an
intersection criterion for acceptance (Conlan et al., 2012; Ratmann et al., 2014), with θi is accepted
when all Sij lie within ABC tolerance bounds, so that δ(θi, α) =
∏J
j=1 δj(θi, αj).
At the first IMABC step, a sample of N0 points is drawn from the prior distribution of model
parameters, pi(θ). The algorithm then enters an updating phase. The (t + 1)st iteration in the
IMABC algorithm proceeds as outlined below:
Step 1: Identify the best points and sample new points nearby
1A. Calculate p-values, ρij , for each accepted θi, based on two-sided tests of H0: Sij = Oj versus
HA: Sij 6= Oj for j = 1, . . . , J , treating Sij as fixed and Oj as estimated with error. Often,
as in our application, Oj is a summary statistic, and is approximately normally distributed.
We summarize model fit across multiple targets with ρi· = mini(ρij), the worst fit across the
J targets.
1B. Select the N (c) points with the largest ρi·. When there are ties, calculate the distance between
the simulated and observed targets, di· =
∑
j:αj<α∗j
dij where dij = (Sij −Oj)2/O2j and select
points with the largest ρi· and smallest di·.
1C. Simulate B new draws around each of the θ
(t+1)
(k) , k = 1, . . . , N
(c) best points by sampling from
a normal distribution with mean θ
(t+1)
(k) and covariance Σ
(t+1)
(k) .
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Let p be the dimension of θ (i.e., the number of calibrated parameters). If there are fewer than
5p accepted points, then Σ
(t+1)
(k) is set to a diagonal covariance matrix with standard deviation
set to half the prior distribution standard deviation for each parameter. If there are at least
5p and up to 25p accepted points, Σ
(t+1)
(k) is calculated using all accepted points. If there are
more than 25p accepted points, Σ
(t+1)
(k) is calculated using the 25p accepted points nearest
to θ
(t+1)
(k) . This means that until the algorithm accepts 25p points, the the same covariance
matrix is used for all normal mixtures.
1D. Simulate calibration targets, Sij , for each new draw, and resimulate targets at center points,
θ
(t+1)
(k) . Accept or reject new draws and previously sampled center points based on δ(θi, α
(t)).
Resimulation of targets at center points enables the algorithm to move away from center
points with Sij that are, by chance, similar to Oi.
Step 2: Update Tolerance Intervals
If any α
(t)
j < α
∗
j and there are 50p or more accepted points, check to see if the tolerance can be
updated. Identify i′ associated with the median ρi·, with di· as a tie breaker. For each potentially
updated tolerance level, set α
(t+1)
j = min(ρi′j , α
∗
j ), then update the accepted θ’s, so that they are
based on δ(θi, α
(t+1)), removing up to half of the previously accepted points that are furthest from
the targets.
Step 3: Evaluate Stopping Criteria
If α(t+1) = α∗, calculate sampling weights and the corresponding effective sample size (ESS).
Sampling weights account for sampling of points from the normal mixture rather than the prior
distribution, wi = pi(θi)/qt(θi). The mixture sampling distribution, qt, is given by qt =
N0
Nt
pi +
B
Nt
∑t
s=1
∑N(c)
k=1 H
(s)
k where H
(s)
k is the kth normal distribution at iteration s, given by N(θ
(s)
(k),Σ
(s)
(k)),
and Nt = N0 +N
(c)Bt, the total number of draws through iteration t.
The ESS for the N(t+1) draws is (
∑N(t+1)
i=1 w
2
i )
−1, where wi = 0 if δ(θi, α(t+1)) = 0 (Kish, 1965;
Liu, 2004). The algorithm stops when ESS ≥ Npost, having obtained the desired number of draws
from the posterior distribution. If α(t+1) = α∗ and ESS < Npost the algorithm continues to iterate,
but without further updates to tolerance intervals.
Once the IMABC algorithm is complete, independent draws from the posterior distribution
are simulated by taking a weighted sample from accepted points with replacement, using the wi.
Alternatively, posterior means and 95% credible intervals (CIs) can be estimated using weighted
means and percentiles based on all accepted draws.
When implementing the IMABC algorithm, we recommend using a large initial sample size,
N0, to ensure exploration of the parameter space and because few initially sampled points may lie
in high posterior probability regions. The number of normal mixtures used to draw new points
at each step, N (c), can be selected to optimize use of computing resources. The effective sample
size of the final set of accepted points, Npost, will depend on the planned uses of the calibrated
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targets. For example, 2, 000 is a good choice when the goal is to provide interval estimates of
model predictions based on percentile intervals, but larger samples may be desired when estimating
functions of parameters.
Using IMABC to calibrate an MSM requires multiple model evaluations at each parameter draw
and the user needs to specify mj , the size of the simulated sample used to obtain Sij . mj may be
smaller for common outcomes (such as adenoma prevalence), and larger for rare outcomes (such
as cancer incidence). Setting m too low will result in too much stochastic variation in Sij and
inaccurate identification of acceptable θi. Setting m too high will unnecessarily slow the algorithm.
5 CRC-SPIN 2.0 Calibration Results
5.1 IMABC Implementation
To calibrate CRC-SPIN 2.0, we used N0 = 21, 000 with Latin hypercube sampling from the prior
distribution to ensure coverage of the parameter space at the initial draw. With the exception of
the SEER target, we began with α(0) = 0.0001 and worked toward α∗ = 0.001. For SEER targets
we began with α(0) = 0, accepting all points regardless of nearness to SEER targets, and worked
toward α∗ = 1× 10−9, which results in narrow bands around these registry-based incidence rates.
Tolerance intervals are wider for study-derived targets because of the smaller sample sizes. These
wider tolerance intervals also reflect the greater uncertainty in these targets due to a range of factors
related to their simulation, including uncertainty about population characteristics, sensitivity of
lesion detection, and lesion size measurement and categorization. Because the Corley et al. (2013)
study is based on insured patients who underwent colonoscopies from 1/1/2006 to 12/31/2008,
the observed adenoma incidence rates may be lower than expected because of prior screening and
removal of adenomas. Therfore, we specified asymetric tolerance limits for the Corley et al. (2013)
target, extending the upper tolerance range by adding 0.25Oj to the upper tolerance limit.
To take advantage of high performance computing and parallel processing (Appendix §B), we
used N (c) = 10, drawing B = 1, 000 points from each normal mixture so that 10, 000 new points
were evaluated at each updating iteration. We assumed a normal distribution for sample statistics
when estimating (1−α)×100% confidence intervals and p-values. We set the final effective sample
size, Npost, to 5, 000.
When simulating target data, we used mj equal to 5×104 for Pickhardt et al. (2003); 2×105 for
Corley et al. (2013) and Imperiale et al. (2000); 3×105 for Church (2004), 5×105 for Lieberman et al.
(2008) and 5× 106 for the SEER registry data. To improve efficiency of the IMABC algorithm, we
sequentially calculated Sij for each new θi in Step 1 of the algorithm, working from targets that are
least to most computationally intensive. After calculating each target, we evaluated δj(θi, αj) and
once δj(θi, αj) = 0, the point is rejected without simulating the remaining, more computationally
intensive, targets.
Both the IMABC algorithm and the CRC-SPIN 2.0 model were implemented in the R pro-
gramming language (R Core Team, 2014). They were coupled to produce an integrated, dynamic,
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high-performance computing workflow with the use of the Extreme-scale Model Exploration with
Swift (EMEWS) framework (Ozik et al., 2016). Further details about the computing environment
are provided in Appendix B.
5.2 Posterior Estimates
The IMABC algorithm completed 8 iterations, obtaining 5, 253 parameter draws within tolerance
limits, with an effective sample size of 5, 168 draws from the joint posterior distribution. Sampling
weights ranged from 1.3× 10−4 to 3.20× 10−4, with a mean and median of 1.9× 10−4.
Posterior estimated means and 95% CIs of model parameters were based on weighted means
and percentiles of accepted draws from the joint posterior distribution (shown in Table 1). We
estimated that adenoma risk is higher for men than women, increases with age, and increases
more rapidly at younger (than older) ages. Parameters that govern the time for an adenoma to
reach 10mm were tightly estimated, with the exception of β1R. Consistent with prior limitations,
the model predicted that 0.4% of adenomas in the colon reach 10mm within 10 years (95% CI
(0.4%, 1.0%)) and 1.8% of adenomas in the rectum reach 10mm within 10 years (95% CI (0.002%,
9.8%)). The predicted percent of adenomas reaching 10mm within 20 years rises to 9.6% (95% CI
(6.8%, 12.3%)) for adenomas in the colon and 59.7% (95% CI (38.8%, 83.3%)) for adenomas in the
rectum. We estimated that adenomas transition to preclinical cancer at smaller sizes for women, for
adenomas in the rectum, and for adenomas initiated at later ages. The gender effect was stronger
for adenomas in the colon than for adenomas in the rectum. We did not find evidence of differential
effects of age at adenoma initiation on size at transition by adenoma location or agent sex (based
on interaction terms γ5, γ6, and γ7). We estimated shorter sojourn times for preclinical cancers in
the colon relative to the rectum. The estimated posterior mean sojourn time is 1.75 years with 95%
CI (1.39, 2.44) for preclinical cancers in the colon and 2.13 with 95% CI (1.42, 3.26) for preclinical
cancers in the rectum.
By simulating draws from the posterior distribution, we were able to examine correlations and
relationships among model parameters. For example, Figure 1 displays the bivariate posterior
distributions of baseline log-adenoma risk (A) and the annual increase in risk between the ages
of 20 and 50 years (α20). When baseline risk is lower, risk increases more rapidly from 20 to 50
years to accurately predict observed adenoma prevalence, which largely is based on prevalence after
age 50 when guidelines recommend initiation of CRC screening (correlation is −0.61). Adenoma
growth parameters also show negative correlation, as demonstrated by the bivariate distribution of
β1R and β2R (correlation is −0.55).
The posterior predicted means of SEER targets were near observed rates and posterior 95% CIs
include SEER targets (Table 2). Posterior 95% CI do not always include other targets (Table 3).
The model predicted higher adenoma prevalence than observed by Corley et al. (2013), especially
at older ages, acknowledging the possibility of prior screening. The model also predicted a larger
number of adenomas ≥10mm than observed by Pickhardt et al. (2003). The probability of detecting
preclinical cancer came from 3 studies, and the accuracy of model predictions demonstrates how
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Figure 1: Joint posterior distribution of model parameters associated with adenoma risk, and the
growth and sojourn time in the colon.
the IMABC calibration approach combines information across potentially conflicting targets.
6 Discussion
We addressed the problem of calibrating microsimulation models by developing IMABC, an ABC
algorithm based on the ideas of incremental mixture importance sampling (IMIS) (Steele et al., 2006;
Raftery and Bao, 2010), an adaptive Sampling Importance Resampling algorithm (SIR; Rubin,
1987). We illustrate our approach by calibrating CRC-SPIN 2.0, an MSM for colorectal cancer, a
problem that involves a relatively high dimensional parameter space and multiple targets.
Like IMIS, the IMABC algorithm iteratively updates the proposal distribution at each itera-
tion to obtain samples from regions of the parameter space that are consistent with calibration
targets. The resulting mixture of normal distributions with locally adaptive covariance matrices is
a very flexible distribution, and the algorithm can sample from a distribution that is multimodal
to better approximate the posterior distribution. In terms of ABC algorithms, IMABC uses a new
approach to selecting tolerance levels, based on α-levels associated with a test of equality between
the simulated and observed targets, which implicitly incorporates the precision of calibration tar-
gets. IMABC also provides an automated approach to tuning these tolerance intervals, requiring
users to specifiy only the initial and final values whereas ABC-SMC requires prespecification of the
sequence of tolerance intervals.
Other advantages of IMABC include clear stopping rules based on the effective sample size,
the ability to specify which targets are most important through final tolerance intervals, and the
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ability to take advantage of parallelized code. A limitation of the IMABC algorithm, especially as
applied to MSM calibration, is that IMABC can be computationally demanding. Evaluation of a
very large number of points may be necessary, and calibration targets must be simulated for each
point. The computational expense can be reduced through the ordering of target evaluations, and
ceasing evaluation of a point when the first set of targets fails to fall within tolerance bounds. We
implemented IMABC as a dynamic high-performance computing (HPC) workflow via the EMEWS
framework (Ozik et al., 2016). While the HPC environment was advantageous for development of
the IMABC approach, we found that it was not ultimately necessary for its application.
Future work will explore the release of publicly available code to allow others to utilize IMABC.
In addition, because calibration to summary statistics requires simulation of a large number of
model evaluations, each with a large number of agents, we plan to explore ways to improve the
efficiency of IMABC model calibration. We also plan to examine efficient approaches to parameter
updating when new targets become available, and sequential calibration approaches that can be
used to efficiently build from simpler to more complex models.
A CRC-SPIN 2.0: Additional Model Information
This appendix provides information about the CRC-SPIN 2.0 model that that may be useful for
understanding the model, but is not essential to understanding the calibration approach. Complete
model description can be found on the cancer.cisnet.gov (National Cancer Institute, 2018), in
the section describing model profiles.
A.1 Adenoma Risk Model
Once adenomas are initiated, they are assigned a location. The distribution of adenomas through-
out the large intestine follows a multinomial distribution based on data from 9 autopsy studies
(Blatt, 1961; Chapman, 1963; Stemmermann and Yatani, 1973; Eide and Stalsberg, 1978; Rick-
ert et al., 1979; Williams et al., 1982; Bombi, 1988; Johannsen et al., 1989; Szczepanski et al.,
1992). The probabilities associated with six sites in the large intestine (from distal to proximal)
are: P(rectum) = 0.09; P(sigmoid colon) = 0.24; P(descending colon) = 0.12; P(transverse colon)
= 0.24; P(ascending colon) = 0.23; and P(cecum) = 0.08. For many purposes it is important to
distinguish between colon and rectal locations; more detailed location information is sometimes
used for determining screening test accuracy.
A.2 Adenoma Growth Model
The diameter of the jth adenoma in the ith agent at time t after onset is given by
dij(t) = d∞
[
1 +
((
d0
d∞
)1/p
− 1
)
exp(−λijt)
]
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where d∞ = 50 is the maximum adenoma diameter in millimeters (mm), d0 = 1mm is the minimum
adenoma diameter, p = 3, corresponding to the von Bertalanffy growth model, and λij is the growth
rate for the jth adenoma within the ith agent. CRC-SPIN 1.0 specified p = 1, corresponding to
the negative exponential model, but this resulted in relatively faster early adenoma growth and too
few small adenomas.
We parameterized the growth model in terms of the time it takes for the adenoma diameter
to reach 10mm to improve our ability to relate adenoma growth to observable data and clinical
knowledge. The growth rate, λij , can easily be calculated given the time to reach 10mm.
A.3 Model for Transition from Adenoma to Preclinical Invasive Cancer
The CRC-SPIN 2.0 model for adenoma transition is a reparameterized version of the CRC-SPIN 1.0
model for adenoma transition, restated as a regression model to better evaluate differences based
on agent and adenoma characteristics.
A.4 Model for Sojourn Time
CRC-SPIN 2.0 uses a Weibul for sojourn times. This allows longer sojourn times and better aligns
with findings from previous studies than the log-normal model used in Version 1.0. For example,
data from the TAMACS study (Chen et al., 1999), reported an estimated mean sojourn time of
2.85 years with a 95% confidence interval (2.15, 4.30).
A.5 Simulation of Lifespan and Colorectal Cancer Survival
The CRC-SPIN 2.0 model first simulates the stage at clinical detection given sex and age at
detection, and then simulates size at detection conditional on stage. (In contrast, the CRC-SPIN 1.0
model simulated size, and then stage conditional on size.)
A.6 Simulated Screening
Colonoscopy sensitivity for adenoma and preclinical CRC detection is based on a quadratic function
of lesion size (s) that was successfully used in the CRC-SPIN 1.0 model. For adenomas, we assume
P (miss|size = s ≤ 15mm) = 0.34 − 0.0349s + 0.0009s2, P (miss|size = 15 < s ≤ 30mm) = 0.01,
P (miss|size = 30 < s ≤ 40mm) = 0.005 and P (miss|size = s ≥ 40mm) = 0.001. This function
results in sensitivity that is consistent with observed findings from the 1990’s (Hixson et al., 1990;
Rex et al., 1997): sensitivity is 0.76 for a 3mm adenoma, 0.87 for a 7.5mm adenoma, and 0.95 for
a 12mm adenoma. For preclinical cancers, we assume sensitivity that is the maximum of 0.95 and
sensitivity based on adenoma size, so that colonoscopy sensitivity is 0.95 for preclinical cancers
12mm or smaller, and sensitivity is greater than 0.95 for preclinical cancers larger than 12mm.
Participants in the Pickhardt et al. (2003) study underwent both CT colonography (CTC) and
colonoscopy for the purposes of evaluating the accuracy of CTC, primarily for adenomas 6mm and
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larger. The sensitivities reported by Pickhardt et al. (2003) are consistent with those used for
onetime colonoscopy.
B Programming and Computing Environment
We utilized the EMEWS framework (Ozik et al., 2016) to implement a dynamic HPC workflow
controlled by the IMABC algorithm. EMEWS, built on the general-purpose parallel scripting
language Swift/T (Wozniak et al., 2013), allows for the direct integration of multi-language software
components, in this case IMABC and CRC-SPIN 2.0, and can be used on computing resources
ranging from desktops and campus clusters to supercomputers. The resulting IMABC EMEWS
workflow is driven directly by the IMABC R source code, obviating the need for porting the
code to alternate programming languages or platforms for the sole purpose of running large-scale
computational experiments.
The experiments were performed on the Cray XE6 Beagle at the University of Chicago, hosted
at Argonne National Laboratory. Beagle has 728 nodes, each with 2 AMD Operton 6300 processors,
each having 16 cores, for a total of 32 cores per node; the system thus has 23,296 cores in all. Each
node has 64 GB of RAM. Experiments were also run on the Midway2 cluster at the University of
Chicago Research Computing Center. Midway2 is a hybrid cluster, including both CPU and GPU
resources. For this work, the CPU resources were used, consisting of 370 nodes of Intel E5-2680v4
processors, each with 28 cores and 64 GB of RAM. Swift/T, with the underlying EMEWS workflow
engine, allows for the abstraction of resource specific settings (e.g., scheduler type and compute
layouts) for a variety of target computing resources. Thus, once the IMABC EMEWS workflow was
developed, it could be run on both the Beagle and Midway2 clusters with only minimal configuration
modifications.
The experiment reported here used 80 nodes on Beagle with 4 worker processes per node (to
account for the memory footprint of CRC-SPIN 2.0) for a total of 320 worker processes, each of
which could concurrently execute an individual model run. The total compute time was 29.4 hours
or 2,352 node-hours.
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